Respiri Ltd (RSH) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.863x

Based on the latest financial reports, Respiri Ltd (RSH) has a cash flow conversion efficiency ratio of -0.863x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.16 Million ≈ $-2.94 Million USD) by net assets (AU$4.82 Million ≈ $3.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RSH stock market capitalisation for the company's overall valuation and market capitalisation.

Respiri Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Respiri Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Respiri Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Respiri Ltd ranked by their cash flow conversion efficiency. Explore RSH cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
SBH Marine Holdings Berhad
KLSE:0300
-0.034x
Culp, Inc. Common Stock
NASDAQ:CULP
-0.022x
Filana Therapeutics, Inc.
NASDAQ:FLNA
-0.061x
Brera Holdings PLC
NASDAQ:SLMT
-0.054x
Oricom Inc
KQ:010470
0.142x
ALANDEQGRP FPO
AU:AEG
-1.327x
Hsinjing Holding Co Ltd
TWO:3713
0.028x
Orient Paper & Industries Limited
NSE:ORIENTPPR
-0.008x

Annual Cash Flow Conversion Efficiency for Respiri Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Respiri Ltd from 2001 to 2024. View current stock price of Respiri Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-06-30 AU$2.64 Million
≈ $1.87 Million
AU$-6.64 Million
≈ $-4.70 Million
-2.519x +53.62%
2023-06-30 AU$826.89K
≈ $585.08K
AU$-4.49 Million
≈ $-3.18 Million
-5.430x -92.66%
2022-06-30 AU$3.01 Million
≈ $2.13 Million
AU$-8.48 Million
≈ $-6.00 Million
-2.819x -190.73%
2021-06-30 AU$7.57 Million
≈ $5.36 Million
AU$-7.34 Million
≈ $-5.19 Million
-0.969x +48.41%
2020-06-30 AU$2.49 Million
≈ $1.77 Million
AU$-4.69 Million
≈ $-3.32 Million
-1.879x -145.80%
2019-06-30 AU$-1.56 Million
≈ $-1.11 Million
AU$-6.41 Million
≈ $-4.54 Million
4.103x +426.08%
2018-06-30 AU$1.65 Million
≈ $1.17 Million
AU$-2.08 Million
≈ $-1.47 Million
-1.258x +22.74%
2017-06-30 AU$1.80 Million
≈ $1.27 Million
AU$-2.93 Million
≈ $-2.07 Million
-1.629x -175.09%
2016-06-30 AU$4.04 Million
≈ $2.86 Million
AU$-2.39 Million
≈ $-1.69 Million
-0.592x +60.81%
2015-06-30 AU$3.90 Million
≈ $2.76 Million
AU$-5.89 Million
≈ $-4.17 Million
-1.511x -50.70%
2014-06-30 AU$9.08 Million
≈ $6.42 Million
AU$-9.10 Million
≈ $-6.44 Million
-1.002x +67.05%
2013-06-30 AU$1.62 Million
≈ $1.15 Million
AU$-4.94 Million
≈ $-3.49 Million
-3.042x -31.80%
2012-06-30 AU$2.11 Million
≈ $1.50 Million
AU$-4.88 Million
≈ $-3.45 Million
-2.308x +9.05%
2011-06-30 AU$2.11 Million
≈ $1.49 Million
AU$-5.35 Million
≈ $-3.79 Million
-2.538x -42.04%
2010-06-30 AU$2.87 Million
≈ $2.03 Million
AU$-5.12 Million
≈ $-3.62 Million
-1.787x -100.81%
2009-06-30 AU$3.93 Million
≈ $2.78 Million
AU$-3.50 Million
≈ $-2.47 Million
-0.890x +25.57%
2008-06-30 AU$4.85 Million
≈ $3.43 Million
AU$-5.80 Million
≈ $-4.10 Million
-1.195x -25.66%
2007-06-30 AU$2.41 Million
≈ $1.70 Million
AU$-2.29 Million
≈ $-1.62 Million
-0.951x +43.74%
2006-06-30 AU$388.37K
≈ $274.80K
AU$-656.61K
≈ $-464.60K
-1.691x -220.00%
2005-06-30 AU$1.51 Million
≈ $1.07 Million
AU$-798.42K
≈ $-564.93K
-0.528x +2.81%
2004-06-30 AU$1.14 Million
≈ $808.22K
AU$-620.94K
≈ $-439.36K
-0.544x +93.29%
2002-06-30 AU$1.38 Million
≈ $976.29K
AU$-11.18 Million
≈ $-7.91 Million
-8.103x -1073.26%
2001-06-30 AU$13.28 Million
≈ $9.40 Million
AU$-9.17 Million
≈ $-6.49 Million
-0.691x --

About Respiri Ltd

AU:RSH Australia Medical Devices
Market Cap
$39.01 Million
AU$55.13 Million AUD
Market Cap Rank
#22901 Global
#837 in Australia
Share Price
AU$0.04
Change (1 day)
+0.00%
52-Week Range
AU$0.04 - AU$0.04
All Time High
AU$0.24
About

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limi… Read more